345 related articles for article (PubMed ID: 8574043)
1. Superparamagnetic iron oxide hepatic MR imaging: efficacy and safety using conventional and fast spin-echo pulse sequences.
Schwartz LH; Seltzer SE; Tempany CM; Silverman SG; Piwnica-Worms DR; Adams DF; Herman L; Herman LA; Hooshmand R
J Magn Reson Imaging; 1995; 5(5):566-70. PubMed ID: 8574043
[TBL] [Abstract][Full Text] [Related]
2. Hepatic metastases: diffusion-weighted sensitivity-encoding versus SPIO-enhanced MR imaging.
Nasu K; Kuroki Y; Nawano S; Kuroki S; Tsukamoto T; Yamamoto S; Motoori K; Ueda T
Radiology; 2006 Apr; 239(1):122-30. PubMed ID: 16493012
[TBL] [Abstract][Full Text] [Related]
3. The value of fast and ultrafast T2-weighted MR imaging sequences in hepatic enhancement with ferumoxides: comparison with conventional spin-echo sequence.
Abe Y; Yamashita Y; Namimoto T; Tang Y; Takahashi M
Radiat Med; 2000; 18(2):97-105. PubMed ID: 10888042
[TBL] [Abstract][Full Text] [Related]
4. Detection of focal hepatic lesions: effects of superparamagnetic iron oxide (AMI-25) on magnetic resonance imaging of the liver using T2-weighted fast spin-echo sequences and gradient-and-spin-echo sequences at 1.0 tesla.
Jung G; Krahe T; Kugel H; Gieseke J; Walter C; Lackner K
Invest Radiol; 1998 Feb; 33(2):61-7. PubMed ID: 9493719
[TBL] [Abstract][Full Text] [Related]
5. Focal nodular hyperplasia of the liver on ferumoxides-enhanced MR imaging: features on conventional spin-echo, fast spin-echo and gradient-echo pulse sequences.
Precetti-Morel S; Bellin MF; Ghebontni L; Zaïm S; Opolon P; Poynard T; Mathurin P; Cluzel P
Eur Radiol; 1999; 9(8):1535-42. PubMed ID: 10525860
[TBL] [Abstract][Full Text] [Related]
6. MR imaging with i.v. superparamagnetic iron oxide: efficacy in the detection of focal hepatic lesions.
Winter TC; Freeny PC; Nghiem HV; Mack LA; Patten RM; Thomas CR; Elliott S
AJR Am J Roentgenol; 1993 Dec; 161(6):1191-8. PubMed ID: 8249724
[TBL] [Abstract][Full Text] [Related]
7. Optimal pulse sequence for ferumoxides-enhanced MR imaging used in the detection of hepatocellular carcinoma: a comparative study using seven pulse sequences.
Kim SH; Choi D; Lim JH; Lee WJ; Jang HJ; Lim HK; Lee SJ; Cho JM; Kim SK; Kim GC
Korean J Radiol; 2002; 3(2):87-97. PubMed ID: 12087198
[TBL] [Abstract][Full Text] [Related]
8. Malignant hepatic tumor detection with ferumoxides-enhanced MR imaging with a 1.5-T system: comparison of four imaging pulse sequences.
Kanematsu M; Itoh K; Matsuo M; Maetani Y; Ametani F; Kondo H; Kato H; Hoshi H
J Magn Reson Imaging; 2001 Feb; 13(2):249-57. PubMed ID: 11169831
[TBL] [Abstract][Full Text] [Related]
9. Characterization of focal liver lesions with superparamagnetic iron oxide-enhanced MR imaging: value of distributional phase T1-weighted imaging.
Lee JM; Kim CS; Youk JH; Lee MS
Korean J Radiol; 2003; 4(1):9-18. PubMed ID: 12679629
[TBL] [Abstract][Full Text] [Related]
10. Fast multiplanar spoiled gradient-recalled imaging of the liver: pulse sequence optimization and comparison with spin-echo MR imaging.
Low RN; Francis IR; Herfkens RJ; Jeffrey RB; Glazer GM; Foo TK; Shimakawa A; Pelc NJ
AJR Am J Roentgenol; 1993 Mar; 160(3):501-9. PubMed ID: 8381572
[TBL] [Abstract][Full Text] [Related]
11. Detection of malignant hepatic lesions before orthotopic liver transplantation: accuracy of ferumoxides-enhanced MR imaging.
Mori K; Scheidler J; Helmberger T; Holzknecht N; Schauer R; Schirren CA; Bittmann I; Dugas M; Reiser M
AJR Am J Roentgenol; 2002 Oct; 179(4):1045-51. PubMed ID: 12239063
[TBL] [Abstract][Full Text] [Related]
12. Characterization of focal hepatic lesions with ferumoxides-enhanced MR imaging: utility of T1-weighted spoiled gradient recalled echo images using different echo times.
Kim JH; Kim MJ; Suh SH; Chung JJ; Yoo HS; Lee JT
J Magn Reson Imaging; 2002 May; 15(5):573-83. PubMed ID: 11997899
[TBL] [Abstract][Full Text] [Related]
13. Improved focal liver lesion detection: comparison of single-shot spin-echo echo-planar and superparamagnetic iron oxide (SPIO)-enhanced MRI.
Coenegrachts K; Orlent H; ter Beek L; Haspeslagh M; Bipat S; Stoker J; Rigauts H
J Magn Reson Imaging; 2008 Jan; 27(1):117-24. PubMed ID: 18050350
[TBL] [Abstract][Full Text] [Related]
14. MRI of liver: a comparison of CNR enhancement using high dose and low dose ferumoxide infusion in patients with colorectal liver metastases.
Scott J; Ward J; Guthrie JA; Wilson D; Robinson PJ
Magn Reson Imaging; 2000 Apr; 18(3):297-303. PubMed ID: 10745139
[TBL] [Abstract][Full Text] [Related]
15. Hepatocellular lesions with increased iron uptake on superparamagnetic iron oxide-enhanced magnetic resonance imaging in cirrhosis or chronic hepatitis: comparison of four magnetic resonance sequences for lesion conspicuity.
Tanabe M; Ito K; Shimizu A; Fujita T; Onoda H; Yamatogi S; Washida Y; Matsunaga N
Magn Reson Imaging; 2009 Jul; 27(6):801-6. PubMed ID: 19144487
[TBL] [Abstract][Full Text] [Related]
16. Detection and segmental location of malignant hepatic tumors: comparison of ferumoxides-enhanced gradient-echo and T2-weighted spin-echo MR imaging.
Van Beers BE; Lacrosse M; Jamart J; Grandin C; Gigot JF; Horsmans Y; Demeure R; Pringot J
AJR Am J Roentgenol; 1997 Mar; 168(3):713-7. PubMed ID: 9057521
[TBL] [Abstract][Full Text] [Related]
17. Detection of hepatocellular carcinoma arising in cirrhotic livers: comparison of gadolinium- and ferumoxides-enhanced MR imaging.
Tang Y; Yamashita Y; Arakawa A; Namimoto T; Mitsuzaki K; Abe Y; Katahira K; Takahashi M
AJR Am J Roentgenol; 1999 Jun; 172(6):1547-54. PubMed ID: 10350287
[TBL] [Abstract][Full Text] [Related]
18. Clinical results with Resovist: a phase 2 clinical trial.
Reimer P; Rummeny EJ; Daldrup HE; Balzer T; Tombach B; Berns T; Peters PE
Radiology; 1995 May; 195(2):489-96. PubMed ID: 7724772
[TBL] [Abstract][Full Text] [Related]
19. Detection of focal liver lesions with superparamagnetic iron oxide: value of STIR and SE imaging.
Halavaara JT; Lamminen AE; Bondestam S; Standertskjöld-Nordenstam CG; Hamberg LM
J Comput Assist Tomogr; 1994; 18(6):897-904. PubMed ID: 7962796
[TBL] [Abstract][Full Text] [Related]
20. Superparamagnetic iron oxide (SPIO)-enhanced liver MRI with ferucarbotran: efficacy for characterization of focal liver lesions.
Namkung S; Zech CJ; Helmberger T; Reiser MF; Schoenberg SO
J Magn Reson Imaging; 2007 Apr; 25(4):755-65. PubMed ID: 17335040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
